TXG
TXG
NASDAQ · Life Sciences Tools & Services

10X Genomics Inc-Class A

Mid-Cap Stocks Healthcare Stocks
$18.39
+0.01 (+0.05%)
As of Mar 22, 10:02 PM ET ·
Analyst Consensus
Hold
22
Analysts
High
Coverage
Buy 8 36%
Hold 14 64%
Sell 0 0%
Price Target
Analyst Price Target +152.3% upside
Low Target $30.79
Average Target $46.39
High Target $59.80
Current Price $18.39
Current
$18.39
Target
$46.39
$30.79 $46.39 avg $59.80
Scenario Analysis
Bear Case
$30.79
67.4%
Low target
Base Case
$46.39
+152.3%
Avg target
Bull Case
$59.80
+225.2%
High target
Risk/Reward
3.3x
Highly favorable
Price in Context
52-Week High
$23.56
-21.9% from high
52-Week Low
$6.78
+171.2% from low
50-Day SMA
$18.75
-1.9% vs SMA
200-Day SMA
$14.19
+29.6% vs SMA
RSI (14)
40.8
Neutral
Target vs 52W High
$46.39
+96.9% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
 Strong Buy 33 88% $369.21 -24.7%
DHR
Danaher Corp
 Strong Buy 30 87% $158.11 -16.8%
A
Agilent Technologies Inc
 Buy 29 72% $64.69 -43.4%
IQV
Iqvia Holdings Inc
 Strong Buy 30 80% $82.96 -50.1%
MTD
Mettler-Toledo International
 Hold 21 43% $170.43 -86.5%
ILMN
Illumina Inc
 Hold 28 54% $169.36 +34.4%
WAT
Waters Corp
 Buy 28 57% $189.60 -37.2%
WST
West Pharmaceutical Services
 Strong Buy 23 78% $136.24 -44.5%